Status:
COMPLETED
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Post-Menopausal Osteoporosis
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
This 2 arm study will assess the long-term efficacy and safety of oral treatment with 100mg or 150mg Bonviva in women with post-menopausal osteoporosis who have previously completed Bonviva study BM16...
Eligibility Criteria
Inclusion
- successful completion of Bonviva study BM16549, with at least 75% compliance;
- ambulatory.
Exclusion
- malignant disease diagnosed within the previous 12 years (except basal cell cancer that has been successfully removed);
- breast cancer diagnosed within the previous 22 years.
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
719 Patients enrolled
Trial Details
Trial ID
NCT00081653
Start Date
May 1 2004
End Date
May 1 2008
Last Update
July 14 2017
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda, California, United States, 92357
2
Lakewood, Colorado, United States, 80260
3
Omaha, Nebraska, United States, 68131
4
Livingston, New Jersey, United States, 07039